These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

45 related items for PubMed ID: 1988671

  • 21. Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
    Fiedler VB, Perzborn E, Seuter F.
    Pharmacotherapy; 1991; 11(1):77-84. PubMed ID: 2020615
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model.
    Toki Y, Hieda N, Torii T, Hashimoto H, Ito T, Ogawa K, Satake T.
    Prostaglandins; 1988 Apr; 35(4):555-71. PubMed ID: 3150113
    [Abstract] [Full Text] [Related]

  • 28. Increased production of arachidonate metabolites in an occlusion-reperfusion model of canine myocardial infarction.
    Kuzuya T, Hoshida S, Nishida M, Kim Y, Kamada T, Tada M.
    Cardiovasc Res; 1987 Aug; 21(8):551-8. PubMed ID: 3128403
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M, Rovati GE, Cavanillas AB.
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Cell damage as reason for the formation of unsaturated fatty acid hydroperoxides].
    Hölzel C, Spiteller G.
    Naturwissenschaften; 1995 Oct; 82(10):452-60. PubMed ID: 8524416
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size.
    Hahn RA, MacDonald BR, Simpson PJ, Potts BD, Parli CJ.
    J Pharmacol Exp Ther; 1990 Apr; 253(1):58-66. PubMed ID: 2158553
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injury.
    Hahn RA, MacDonald BR, Chastain M, Grinnell BW, Simpson PJ.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1104-10. PubMed ID: 8786541
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of LY233569 on 5-lipoxygenase and reperfusion injury of ischemic myocardium.
    Hahn RA, MacDonald BR, Simpson PJ, Wang L, Towner RD, Ho PP, Goodwin M, Breau AP, Suarez T, Mihelich ED.
    J Pharmacol Exp Ther; 1991 Jan; 256(1):94-102. PubMed ID: 1988671
    [Abstract] [Full Text] [Related]

  • 40. Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size.
    Hahn RA, MacDonald BR, Simpson PJ, Potts BD, Parli CJ.
    J Pharmacol Exp Ther; 1990 Apr; 253(1):58-66. PubMed ID: 2158553
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.